Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2022 Sep 23

PMID 36143863

Authors

Akshay Machanahalli Balakrishna

Vuha Reddi

Peter Matthew Belford

Manrique Alvarez

Wissam A Jaber

David X Zhao

Saraschandra Vallabhajosyula

Affiliations

Soon will be listed here.

Abstract

Pulmonary embolism (PE) can have a wide range of hemodynamic effects, from asymptomatic to a life-threatening medical emergency. Pulmonary embolism (PE) is associated with high mortality and requires careful risk stratification for individualized management. PE is divided into three risk categories: low risk, intermediate-risk, and high risk. In terms of initial therapeutic choice and long-term management, intermediate-risk (or submassive) PE remains the most challenging subtype. The definitions, classifications, risk stratification, and management options of intermediate-risk PE are discussed in this review.

Citing Articles

Role of right/left ventricular diameter ratio in therapy selection for high and low intermediate‑risk pulmonary embolism in the Emergency Department.

Karakaya E, Sonmez B, Cigsar G, Sirin I, Suer Dogan I Exp Ther Med. 2025; 29(4):73.

PMID: 39991720 PMC: 11843200. DOI: 10.3892/etm.2025.12823.

Dynamic EIT technology for real-time non-invasive monitoring of acute pulmonary embolism: a porcine model experiment.

Li J, Zhu M, Guo Y, Li W, He Q, Wang Y Respir Res. 2025; 26(1):7.

PMID: 39780173 PMC: 11715541. DOI: 10.1186/s12931-024-03090-9.

Machine Learning-Based Prediction of Pulmonary Embolism Prognosis Using Nutritional and Inflammatory Indices.

Lian Z, Wei X, Chai D Clin Appl Thromb Hemost. 2024; 30:10760296241300484.

PMID: 39552298 PMC: 11571247. DOI: 10.1177/10760296241300484.

NUPR1 modulates pulmonary embolism progression via smooth muscle cells phenotypic transformation.

Wang S, Xu A, Chen M, Wu Y Heliyon. 2024; 10(21):e38918.

PMID: 39524834 PMC: 11550085. DOI: 10.1016/j.heliyon.2024.e38918.

Traumatic Pulmonary Embolism.

Ventrapragada K, Wright A, Tahir S, Tartaglia L, Ganti L Cureus. 2024; 16(7):e64614.

PMID: 39156300 PMC: 11328824. DOI: 10.7759/cureus.64614.

References

Meinel F, Nance Jr J, Schoepf U, Hoffmann V, Thierfelder K, Costello P . Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis. Am J Med. 2015; 128(7):747-59.e2. DOI: 10.1016/j.amjmed.2015.01.023. View

Fernandez C, Bova C, Sanchez O, Prandoni P, Lankeit M, Konstantinides S . Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism. Chest. 2015; 148(1):211-218. DOI: 10.1378/chest.14-2551. View

Hobohm L, Sagoschen I, Habertheuer A, Barco S, Valerio L, Wild J . Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolism. Resuscitation. 2021; 170:285-292. DOI: 10.1016/j.resuscitation.2021.10.007. View

Becattini C, Agnelli G, Salvi A, Grifoni S, Pancaldi L, Enea I . Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res. 2009; 125(3):e82-6. DOI: 10.1016/j.thromres.2009.09.017. View

Weinstein T, Deshwal H, Brosnahan S . Advanced management of intermediate-high risk pulmonary embolism. Crit Care. 2021; 25(1):311. PMC: 8406617. DOI: 10.1186/s13054-021-03679-2. View

Goldhaber S, Haire W, Feldstein M, Miller M, Toltzis R, Smith J . Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993; 341(8844):507-11. DOI: 10.1016/0140-6736(93)90274-k. View

Jimenez D, Aujesky D, Moores L, Gomez V, Lobo J, Uresandi F . Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010; 170(15):1383-9. DOI: 10.1001/archinternmed.2010.199. View

Khandhar S, Mehta M, Cilia L, Palevsky H, Matthai W, Rivera-Lebron B . Invasive hemodynamic assessment of patients with submassive pulmonary embolism. Catheter Cardiovasc Interv. 2019; 95(1):13-18. DOI: 10.1002/ccd.28491. View

Lankeit M, Friesen D, Schafer K, Hasenfuss G, Konstantinides S, Dellas C . A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin Res Cardiol. 2012; 102(1):73-80. PMC: 3536952. DOI: 10.1007/s00392-012-0498-1. View

10.

Sanchez O, Trinquart L, Colombet I, Durieux P, Huisman M, Chatellier G . Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J. 2008; 29(12):1569-77. DOI: 10.1093/eurheartj/ehn208. View

11.

Kline J, Hall C, Jones A, Puskarich M, Mastouri R, Lahm T . Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial. Am Heart J. 2017; 186:100-110. PMC: 5412723. DOI: 10.1016/j.ahj.2017.01.011. View

12.

Konstantinides S, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J . Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. J Am Coll Cardiol. 2017; 69(12):1536-1544. DOI: 10.1016/j.jacc.2016.12.039. View

13.

Toma C, Bunte M, Cho K, A Jaber W, Chambers J, Stegman B . Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry. Catheter Cardiovasc Interv. 2022; 99(4):1345-1355. PMC: 9542558. DOI: 10.1002/ccd.30091. View

14.

Pelliccia F, De Luca A, Pasceri V, Tanzilli G, Speciale G, Gaudio C . Safety and Outcome of Rheolytic Thrombectomy for the Treatment of Acute Massive Pulmonary Embolism. J Invasive Cardiol. 2020; 32(11):412-416. DOI: 10.25270/jic/20.00173. View

15.

Lauque D, Maupas-Schwalm F, Bounes V, Juchet H, Bongard V, Roshdy A . Predictive value of the heart-type fatty acid-binding protein and the Pulmonary Embolism Severity Index in patients with acute pulmonary embolism in the emergency department. Acad Emerg Med. 2014; 21(10):1143-50. DOI: 10.1111/acem.12484. View

16.

Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K . Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation. 1997; 96(3):882-8. DOI: 10.1161/01.cir.96.3.882. View

17.

Nguyen P, Stevens H, Peter K, McFadyen J . Submassive Pulmonary Embolism: Current Perspectives and Future Directions. J Clin Med. 2021; 10(15). PMC: 8347177. DOI: 10.3390/jcm10153383. View

18.

Jaff M, McMurtry M, Archer S, Cushman M, Goldenberg N, Goldhaber S . Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011; 123(16):1788-830. DOI: 10.1161/CIR.0b013e318214914f. View

19.

Elder M, Blank N, Kaki A, Alraies M, Grines C, Kajy M . Mechanical circulatory support for acute right ventricular failure in the setting of pulmonary embolism. J Interv Cardiol. 2018; 31(4):518-524. DOI: 10.1111/joic.12503. View

20.

Goldhaber S . PEITHO Long-Term Outcomes Study: Data Disrupt Dogma. J Am Coll Cardiol. 2017; 69(12):1545-1548. DOI: 10.1016/j.jacc.2017.01.027. View